(l12)
Open as .pdf
See at PubMed | Where to Begin? Thirty must-read papers for newcomers to pharmacoepidemiology
Pottegård A, Morin L, Hallas J, Gerhard T, Winterstein AG, Perez-Gutthann S, Tadrous M.
Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):257-259
|
(l11)
Open as .pdf
See at PubMed | Randomization versus Real-World Evidence
Winterstein AG, Girman CJ, Pottegård A.
N Engl J Med. 2020 Jul 23;383(4):e21.
|
(l10)
Open as .pdf
See at PubMed | Author Response: Use of ß2-adrenoreceptor Agonist and Antagonist Drugs and Risk of Parkinson Disease
Pottegård A, Hopfner F, Wod M, Höglinger GU, Blaabjerg M, Rösler TW, Kuhlenbäumer G, Christensen K, Desuchl G.
Neurology. 2020 May 19;94(20):899.
|
(l9)
Open as .pdf
See at PubMed | Cohort selection in register-based studies of direct oral anticoagulant users with atrial fibrillation: An inevitable trade-off between selection bias and misclassification
Hellfritzsch M, Pottegård A, Haastrup SB, Rasmussen L, Grove EL.
Basic Clin Pharmacol Toxicol. 2020 May 4.
|
(l8)
Open as .pdf
See at PubMed | Comment on "Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea"
Pottegård A, Morales D.
Korean J Intern Med. 2020 Jul;35(4):1014-1015.
|
(l7)
Open as .pdf
See at PubMed | Time for integrating clinical, lifestyle and molecular data to predict drug responses - Authors' reply.
Pottegård A, Friis S, Christensen RP, Habel LA, Gagne JJ, Hallas J.
EBioMedicine. 2016 May;7:11
|
(l6)
Open as .pdf
See at PubMed | Re: Pregabalin prescriptions in the United Kingdom - a drug utilisation study of The Health Improvement Network (THIN) primary care database by Asomaning et al.
Pottegård A, Tjäderborn M, Schjerning O, Nielsen J, Damkier P, Bodén R.
Int J Clin Pract. 2016 Aug;70(8):696
|
(l5)
Open as .pdf
See at PubMed | Inconsistencies in reporting of renal elimination among NOACs: the case of apixaban
Hellfritzsch M, Damkier P, Pottegård A, Grønlykke T, Grove EL.
Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):346-8
|
(l4)
See at PubMed | Re: In utero SSRI exposure and risk of clubfoot
Henriksen DP, Pottegård A, Jimenez-Solem E, Damkier P.
Epidemiology. 2015 May;26(3):e34-5
|
(l3)
Open as .pdf
See at PubMed | Pregnancy and paracetamol: Methodological considerations on the study of associations between in utero exposure to drugs and childhood neurodevelopment
Damkier P, Pottegård A, Christensen RD, Hallas J.
Basic Clin Pharmacol Toxicol. 2015 Jan;116(1):2-5
|
(l2)
Open as .pdf
See at PubMed | Reply to "Evidence for harm, comment on..." by Kripke & Langer
Pottegård A, Friis S, Andersen M, Hallas J.
Br J Clin Pharmacol. 2014 Jul;78(1):188-9
|
(l1)
Open as .pdf
| Hypnotics' association with mortality or cancer: bias related to the study design and analysis
Andersen M, Pottegård A, Friis S, Hallas J.
|
|
|
